<DOC>
	<DOCNO>NCT00156364</DOCNO>
	<brief_summary>A . To study effect pancreas transplantation ( PT ) structural abnormality diabetic nephropathy ( DN ) patient type 1 ( insulin-dependent ) diabetes mellitus ( type 1 D ) . These study address influence long-term normoglycemia two stage diabetic renal disease . Due difficulty encounter recruitment patient agree undergo GFR native kidney biopsy conjunction clinical evaluation visit transplant , focus effort obtain skin biopsy previous transplant , regular interval ( 3 , 6 , 9 month , yearly ) follow successful transplantation . - Pancreas Transplantation Alone ( PTA ) . To determine , 5 , 10 , 15 year PTA , effect normoglycemia establish lesion DN long-term type 1 D patient ' kidney . - Islet Transplantation Alone ( ITA ) . To determine , 5 year ITA , effect normoglycemia early lesion DN type 1 D patient ' kidney . - Pancreas Transplantation Kidney Transplantation ( PAK ) . To determine 5-10 year effect normoglycemia early structural lesion DN kidney transplant year earlier type 1 D recipient . Hypothesis : The benefit PT early glomerular lesion DN demonstrable 5 year kidney expose diabetes short duration , patient long-standing type 1 D advance glomerular DN lesion , long exposure euglycemia necessary demonstrate arrest regression lesion .</brief_summary>
	<brief_title>Studies Organ Transplantation Animals Man</brief_title>
	<detailed_description>These continuation study focus large pancreas ( PTx ) kidney ( KTx ) transplant population type 1 diabetic ( D ) patient ( pt ) order well understand diabetic nephropathy ( DN ) , lead cause renal failure . Objectives : ( ) determine whether PTx readily arrest reverse early vs. establish lesion DN ; ( b ) continue study renal structural-functional relationship DN , emphasis multifaceted pathologic DN lesion , include glomerular , vascular , interstitial lesion glomerular-tubular connection ; ( c ) continue study DN natural history role renal biopsy predict outcome ; ( ) quantitate understand basis atubular glomerulus ( AG ) DN ; ( e ) elucidate glomerular ( glom ) epithelial cell abnormality DN ; ( f ) study glom extracellular matrix abnormality DN ; ( g ) study recurrence DN KTx ; ( h ) study molecular/genetic basis DN develop cellular marker DN risk ; ( ) determine long-term ( 10-15 yr ) structural consequence cyclosporine ( CSA ) native kidney PTx recipient ; ( j ) determine shorter-term ( 5 yr ) consequences Prograf native kidney PTx recipient compare see 5 year CSA treatment . Together , study help elucidate pathogenesis natural history DN , unravel molecular genetic aspect disease , describe dynamic DN reversal PTx pt , recurrence KTx pt expand knowledge nephrotoxic effect calcinosis inhibitor .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>1 . Pancreas Transplantation . The patient consider recruitment evaluate pancreas transplant alone pancreas transplant kidney transplantation IDDM patient University Minnesota ( U M ) . The consent form approve Institutional Review Board University Minnesota transplant coordinator responsible interact patient continuously utilized consent form recruitment process . 2 . LongTerm Post Kidney Transplant IDDM Patients . These patient recruit study coordinator work directly PI also use consent form approve Institutional Review Board University Minnesota . Pancreas Transplantation Alone 1 . Serum creatinine &gt; 1.5 mg/dl CCr &lt; 50 ml/min/1.73M2 , kidney IDDM patient approach end stage renal disease readily amenable morphometric analysis . 2 . Solitary kidney evidence unilateral renal disease , base upon significant discrepancy renal size ultrasound . 3 . Evidence important kidney disease history , ultrasound , baseline biopsy . 4 . Other chronic disease condition , addition IDDM , cystic fibrosis , serious mental illness , severe mental retardation , etc . 5 . Pregnancy . Pregnancy test perform eligible female childbearing age , pregnant woman exclude . Patients eligible 3 month completion pregnancy . Pancreas Transplantation After Kidney Transplantation 1 . Serum creatinine &gt; 2 mg/dl ; high value accept native kidney patient since patient single kidney receive CSA FK506 . 2 . Moderate severe chronic rejection baseline biopsy . 3 . Evidence important kidney disease history , ultrasound , baseline biopsy . 4 . Other chronic disease condition , addition IDDM , cystic fibrosis , serious mental illness , severe mental retardation , etc . 5 . Pregnancy . Pregnancy test perform eligible female childbearing age , pregnant woman exclude . Patients eligible 3 month completion pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Diabetic Nephropathy</keyword>
	<keyword>Kidney Transplant</keyword>
	<keyword>Pancreas Transplant</keyword>
	<keyword>Renal Interstitium</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Cyclosporine</keyword>
	<keyword>Tacrolimus</keyword>
</DOC>